Go, Se-Il <br/><br/>
CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.  [electronic resource] 

 -  Cancer research and treatment  Jan 2016 
 - 142-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2005-9256 
<br/><br/><label>Standard No.: </label>10.4143/crt.2014.227  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor<br/>Disease Progression<br/>Humans<br/>Hyaluronan Receptors--genetics<br/>Lymphatic Metastasis<br/>Prognosis<br/>Stomach Neoplasms--genetics